Accelerating new product and technology development through development investment in growth areas
First written in FY2016. 22 of 30 entries say "Restated". Latest entry: 2026-07-31.
2 other companies' latest entry also says "Advanced".
- 2026-07-31AdvancedEarnings presentation materials
「At our Kawasaki Works, we began demonstration testing of a methanation unit (press release issued in June this year).」
R&D in growth areas progressed to the demonstration phase for carbon-recycling technology combined with CO2 capture equipment. - FY2026AdvancedAnnual report
「R&D expenses by segment for the consolidated fiscal year totaled ¥815 million, comprising ¥71 million for the Engineering Business, ¥84 million for the Standalone Machinery Business and ¥659 million for the GX Business.」
Total R&D expenses were ¥815 million, of which ¥659 million was allocated to the GX Business. The Group is expanding into areas including HyDel, microalgae, Ele-Fil, CO2 separation membranes, and ammonia and hydrogen utilization. - FY2026-H1RestatedAnnual report
「The amount spent on the Group's R&D activities during the interim consolidated accounting period was ¥323 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」
The Group recorded ¥323 million in R&D expenses but reconfirmed that there were no material changes in the status of its R&D activities. - FY2025AdvancedAnnual report
「R&D expenses by segment for the consolidated fiscal year totaled ¥510 million, comprising ¥219 million for the Engineering Business and ¥290 million for the Standalone Machinery Business. The main R&D activities were as follows.」
Total R&D expenses were ¥510 million. The Group is expanding into areas including waste plastics, digestion systems, iFactory, algae, Ele-Fil, CO2 separation membranes, and ammonia and hydrogen utilization. - FY2024AdvancedAnnual report
「R&D expenses by segment for the consolidated fiscal year totaled ¥598 million, comprising ¥292 million for the Engineering Business and ¥306 million for the Standalone Machinery Business.」
Total R&D expenses were ¥598 million, and the Group is advancing development in areas including waste plastics, hydrogen derived from biogas, high-efficiency digestion, iFactory and algae. - FY2024-Q3RestatedAnnual report
「The amount spent on the Group's R&D activities during the first nine months of the fiscal year was ¥449 million. There were no material changes in the status of the Group's R&D activities during the first nine months.」
The Group recorded ¥449 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2024-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥393 million. There were no material changes in the status of the Group's R&D activities during the first six months.」
The Group recorded ¥393 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2024-Q1RestatedAnnual report
「The amount spent on the Group's R&D activities during the first quarter of the fiscal year was ¥83 million. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Group recorded ¥83 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2023-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥99 million. There were no material changes in the status of the Group's R&D activities during the first six months.」
The Group recorded ¥99 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2023-Q1RestatedAnnual report
「The amount spent on the Group's R&D activities during the first quarter of the fiscal year was ¥48 million. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Group recorded ¥48 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2022-Q3RestatedAnnual report
「The amount spent on the Group's R&D activities during the first nine months of the fiscal year was ¥146 million. There were no material changes in the status of the Group's R&D activities during the first nine months.」
The Group recorded ¥146 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2022-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥101 million. There were no material changes in the status of the Group's R&D activities during the first six months.」
The Group recorded ¥101 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities, including development investment in growth fields. - FY2021AdvancedAnnual report
「R&D expenses by segment for the consolidated fiscal year totaled ¥362 million, comprising ¥229 million for the Engineering Business and ¥133 million for the Standalone Machinery Business.」
Total R&D expenses were ¥362 million, up from ¥305 million in the previous fiscal year. The Group continues to upgrade existing technologies, expand into new fields and develop new technologies and products. - FY2021-Q3RestatedAnnual report
「The amount spent on the Group's R&D activities during the first nine months of the fiscal year was ¥237 million. There were no material changes in the status of the Group's R&D activities during the first nine months.」
The Group recorded ¥237 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥126 million. There were no material changes in the status of the Group's R&D activities during the first six months.」
The Group recorded ¥126 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2020-Q3RestatedAnnual report
「The amount spent on the Group's R&D activities during the first nine months of the fiscal year was ¥147 million. There were no material changes in the status of the Group's R&D activities during the first nine months.」
The Group recorded ¥147 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥97 million. There were no material changes in the status of R&D activities during the first six months.」
The Group recorded ¥97 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities, including development investment in growth fields. - FY2019AdvancedAnnual report
「The Group conducts research and development aimed at upgrading existing technologies and various types of equipment, differentiating its technologies and enhancing competitiveness. It is also actively expanding into new fields and developing new technologies and products. R&D expenses by segment for the consolidated fiscal year totaled ¥305 million, comprising ¥151 million for the Engineering Business and ¥154 million for the Standalone Machinery Business.」
Total R&D expenses were ¥305 million, and the Group is advancing the development of new technologies and products, including EGR treatment equipment and iFactory, in addition to upgrading existing technologies. - FY2019-Q3RestatedAnnual report
「The amount spent on the Group's R&D activities during the first nine months of the fiscal year was ¥137 million. There were no material changes in the status of the Group's R&D activities during the first nine months.」
The Group recorded ¥137 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「The amount spent on the Group's R&D activities during the first six months of the fiscal year was ¥62 million. There were no material changes in the status of the Group's R&D activities during the first six months.」
The Group recorded ¥62 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「The amount spent on the Group's R&D activities during the first quarter of the fiscal year was ¥12 million. There were no material changes in the status of the Group's R&D activities during the first quarter.」
The Group recorded ¥12 million in R&D expenses and reconfirmed that there were no material changes in the status of its R&D activities. - FY2018RestatedAnnual report
「The Group conducts research and development aimed at upgrading existing technologies and various types of equipment, differentiating its technologies and enhancing competitiveness. It is also actively expanding into new fields and developing new technologies and products. R&D expenses by segment for the consolidated fiscal year totaled ¥290 million, comprising ¥198 million for the Engineering Business and ¥92 million for the Standalone Machinery Business.」
The Group continues to upgrade and differentiate existing technologies and develop new fields and products. Total R&D expenses were ¥290 million. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities by the group during the first nine months of the current fiscal year was ¥167 million. There were no material changes in the status of the group's research and development activities during the first nine months of the current fiscal year.」
The company recorded ¥167 million in research and development expenses and reaffirmed that there were no material changes in the status of its research and development activities. - FY2018-Q2RestatedAnnual report
「The amount spent on research and development activities by the group during the first six months of the current fiscal year was ¥114 million. There were no material changes in the status of research and development activities during the first six months of the current fiscal year.」
The company states that there were no material changes in the status of its research and development activities and that it is continuing its policy of investing in development in growth areas. - FY2018-Q2RestatedAnnual report
「The amount spent on research and development activities by the group during the first six months of the current fiscal year was ¥114 million. There were no material changes in the status of research and development activities during the first six months of the current fiscal year.」
Research and development expenses were ¥114 million, and the company reaffirmed that there were no material changes in the status of its research and development activities. - FY2018-Q1RestatedAnnual report
「The amount spent on research and development activities by the group during the first three months of the current fiscal year was ¥47 million. There were no material changes in the status of the group's research and development activities during the first three months of the current fiscal year.」
The company recorded ¥47 million in research and development expenses and reaffirmed that there were no material changes in the status of its research and development activities. - FY2017AdvancedAnnual report
「Research and development expenses by segment for the current fiscal year totalled ¥584 million, comprising ¥481 million for the engineering business and ¥102 million for the stand-alone machinery business.」
Research and development expenses increased from ¥343 million in the previous fiscal year to ¥584 million, with development continuing in areas including hydrogen, biogas and equipment complying with marine environmental regulations. - FY2017-Q3RestatedAnnual report
「The amount spent on research and development activities by the group during the first nine months of the current fiscal year was ¥446 million. There were no material changes in the status of the group's research and development activities during the first nine months of the current fiscal year.」
Research and development expenses were ¥446 million. The company explicitly stated that there were no material changes in the status of its research and development activities and that it was continuing its policy of investing in development in growth areas. - FY2017-Q2RestatedAnnual report
「The amount spent on research and development activities by the group during the first six months of the current fiscal year was ¥283 million. There were no material changes in the status of research and development activities during the first six months of the current fiscal year.」
The company recorded ¥283 million in research and development expenses and explicitly stated that there were no material changes in the status of its research and development activities. - FY2016First statedAnnual report
「We will further strengthen our competitiveness as a company by accelerating new product and technology development through proactive development investment in growth areas.」
Research and development expenses were ¥343 million, up from ¥155 million the previous year. The main areas of focus were hydrogen, biogas and equipment complying with marine environmental regulations.